© The Financial Times Ltd 2015 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Aug 21, 2015, the consensus forecast amongst 32 polled investment analysts covering GlaxoSmithKline plc advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Feb 21, 2013. The previous consensus forecast advised that GlaxoSmithKline plc would outperform the market.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 25 analysts offering 12 month price targets for GlaxoSmithKline plc have a median target of 1,500, with a high estimate of 1,800 and a low estimate of 1,250. The median estimate represents a 12.70% increase from the last price of 1,331. View Full Financials
In 2014, GlaxoSmithKline PLC reported a dividend of 0.80 GBP, which represents a 2.56% increase over last year. The 25 analysts covering the company expect dividends of 0.92 GBP for the upcoming fiscal year, an increase of 14.88%. View Full Financials
|Div growth (TTM)||+2.56 %|
On Jul 29, 2015, GlaxoSmithKline plc reported 2nd quarter 2015 earnings of 0.173 per share. This result was in line with the consensus of the 11 analysts following the company and under-performed last year's 2nd quarter results by 8.47 %.
The next earnings announcement is expected on Oct 28, 2015. View Full Interim Financials
|Average growth rate||+1.29 %|
GlaxoSmithKline plc reported annual 2014 earnings of 0.954 per share on Feb 04, 2015.
The next earnings announcement from GlaxoSmithKline plc is expected the week of Feb 08, 2016. View Full Annual Financials
|Average growth rate||-7.49 %|
GlaxoSmithKline plc had 2nd quarter 2015 revenues of 5.89bn. This bettered the 5.88bn consensus of the 12 analysts covering the company. This was 5.88% above the prior year's 2nd quarter results. View Full Interim Financials
|Average growth rate||+1.68 %|
GlaxoSmithKline plc had revenues for the full year 2014 of 23.01bn. This was 13.20 % below the prior year's results. View Full Annual Financials
|Average growth rate||-4.99 %|